BR0307413A - Terapêutica com bloqueadores de aldosterona para prevenção ou tratamento de patologias relacionadas com inflamação - Google Patents
Terapêutica com bloqueadores de aldosterona para prevenção ou tratamento de patologias relacionadas com inflamaçãoInfo
- Publication number
- BR0307413A BR0307413A BR0307413-7A BR0307413A BR0307413A BR 0307413 A BR0307413 A BR 0307413A BR 0307413 A BR0307413 A BR 0307413A BR 0307413 A BR0307413 A BR 0307413A
- Authority
- BR
- Brazil
- Prior art keywords
- inflammation
- prevention
- treatment
- related conditions
- individual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"TERAPêUTICA COM BLOQUEADORES DE ALDOSTERONA PARA PREVENçãO OU TRATAMENTO DE PATOLOGIAS RELACIONADAS COM INFLAMAçãO". Método de prevenção ou tratamento de uma patologia relacionada com inflamação tal como miocardite, cardiomiopatia, vasculite e doença de Behcet num indivíduo, compreendendo o tratamento do indivíduo com uma quantidade terapeuticamente eficaz de um bloqueador de aldosterona suficiente para alterar a expressão de um ou mais produtos de expressão envolvidos, diretamente ou indiretamente, na regulação da inflamação ou remodelação cardíaca no indivíduo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35185102P | 2002-01-25 | 2002-01-25 | |
PCT/US2003/002208 WO2004073602A2 (en) | 2002-01-25 | 2003-01-24 | Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0307413A true BR0307413A (pt) | 2005-05-24 |
Family
ID=32907588
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0307413-7A BR0307413A (pt) | 2002-01-25 | 2003-01-24 | Terapêutica com bloqueadores de aldosterona para prevenção ou tratamento de patologias relacionadas com inflamação |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040037806A1 (pt) |
EP (1) | EP1505983A2 (pt) |
JP (1) | JP2006508174A (pt) |
KR (1) | KR20050004774A (pt) |
CN (1) | CN1638777A (pt) |
AU (1) | AU2002368473A1 (pt) |
BR (1) | BR0307413A (pt) |
CA (1) | CA2478473A1 (pt) |
MX (1) | MXPA04007213A (pt) |
PL (1) | PL373391A1 (pt) |
WO (1) | WO2004073602A2 (pt) |
ZA (1) | ZA200405858B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005099715A2 (en) * | 2004-04-08 | 2005-10-27 | Retmed Pty Ltd. | Treatment of ophthalmic conditions with mineralcorticoids |
US20050232957A1 (en) * | 2004-04-14 | 2005-10-20 | Katz Kenneth A | Compositions and methods for moisturizing skin |
CN105294804A (zh) * | 2015-12-07 | 2016-02-03 | 王海燕 | 一种治疗心力衰竭的药物组合物 |
WO2018027149A1 (en) * | 2016-08-04 | 2018-02-08 | University Of Miami | Methods of treating alport syndrome |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4299767A (en) * | 1978-08-11 | 1981-11-10 | Hoffmann-La Roche Inc. | Benzodiazepine derivatives |
DE4101841C2 (de) * | 1991-01-23 | 1997-02-06 | Schaper & Bruemmer Gmbh | Verwendung von Sabal-Extrakten zum Behandeln von Mammakarzinomen |
US5529992A (en) * | 1992-04-21 | 1996-06-25 | Curators Of The University Of Missouri | Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors |
TW513418B (en) * | 1996-07-31 | 2002-12-11 | Otsuka Pharma Co Ltd | Thiazole derivatives, their production and use |
CO4940430A1 (es) * | 1997-07-07 | 2000-07-24 | Novartis Ag | Compuestos policiclicos que contienen estaurosporina hidrogenada con propiedades farmacologicas convenientes y un efecto inhibidor sobre el crecimiento de las celulas tumorales |
NZ501822A (en) * | 1997-10-02 | 2001-12-21 | Yukijirushi Nyugyo Kabushiki K | Therapeutic agents for male and female sex hormone dependent diseases |
US20030096798A1 (en) * | 1999-11-09 | 2003-05-22 | Williams Gordon H. | Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist |
US6716829B2 (en) * | 2000-07-27 | 2004-04-06 | Pharmacia Corporation | Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders |
CA2416152A1 (en) * | 2000-07-27 | 2002-02-07 | Pharmacia Corporation | Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
-
2003
- 2003-01-24 CN CNA038049813A patent/CN1638777A/zh active Pending
- 2003-01-24 BR BR0307413-7A patent/BR0307413A/pt not_active IP Right Cessation
- 2003-01-24 WO PCT/US2003/002208 patent/WO2004073602A2/en active Search and Examination
- 2003-01-24 MX MXPA04007213A patent/MXPA04007213A/es not_active Application Discontinuation
- 2003-01-24 JP JP2004568540A patent/JP2006508174A/ja not_active Withdrawn
- 2003-01-24 CA CA002478473A patent/CA2478473A1/en not_active Abandoned
- 2003-01-24 PL PL03373391A patent/PL373391A1/xx not_active Application Discontinuation
- 2003-01-24 KR KR10-2004-7011488A patent/KR20050004774A/ko not_active Application Discontinuation
- 2003-01-24 EP EP03815290A patent/EP1505983A2/en not_active Withdrawn
- 2003-01-24 AU AU2002368473A patent/AU2002368473A1/en not_active Abandoned
- 2003-01-24 US US10/350,964 patent/US20040037806A1/en not_active Abandoned
-
2004
- 2004-07-22 ZA ZA200405858A patent/ZA200405858B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1505983A2 (en) | 2005-02-16 |
CA2478473A1 (en) | 2004-09-02 |
WO2004073602A3 (en) | 2004-12-16 |
JP2006508174A (ja) | 2006-03-09 |
AU2002368473A1 (en) | 2004-09-09 |
MXPA04007213A (es) | 2005-02-25 |
WO2004073602A2 (en) | 2004-09-02 |
US20040037806A1 (en) | 2004-02-26 |
CN1638777A (zh) | 2005-07-13 |
KR20050004774A (ko) | 2005-01-12 |
ZA200405858B (en) | 2006-07-26 |
PL373391A1 (en) | 2005-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE418991T1 (de) | Methode zur behandlung von herzrhythmusstörungen mit einem a1 adenosin agonist zusammen mit einem beta blocker | |
UY26464A1 (es) | " compuestos, composiciones y métodos para estimular el crecimiento y elongación de neuronas" | |
BRPI0414277A (pt) | métodos e composições para o tratamento de dor e outras condições mediadas adrenérgicas alfa 2 | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
BR0015604A (pt) | Método para o tratamento de cicatrizes hipertróficas de modo a reduzir o tamanho e/ou melhorar a aparência das mesmas, composições para tratar condições adversas da pele, e, para reduzir o tamanho e melhorar a aparência de cicatrizes hipertróficas | |
BR9909277A (pt) | Compostos com atividade em receptores muscarìnicos | |
BR0309623A (pt) | Agentes que regulam. inibem ou modulam a atividade e/ou a expressão do fator de crescimento de tecido conjuntivo (ctgf) como um único meio de diminuir a pressão intraocular e tratar retinopatias glaucomatosas/neuropatias ópticas | |
CA2388939A1 (en) | Therapeutic treatments for blood cell deficiencies | |
MX2022011550A (es) | Composiciones y métodos para inhibir la expresión de angptl3. | |
MX2021002349A (es) | Inhibidores de calicreína en plasmá y usos de los mismos para tratar ataque de angioedema hereditario. | |
BRPI0413404A (pt) | composições farmacêuticas, métodos de tratamento ou prevenção de disfunções cardìacas, métodos de aumento da função cardìaca e método de identificação de inibidor de mif | |
AR004494A1 (es) | Una celula util para el tratamiento del dolor, un metodo para producirla, un organo bioartificial de la comprende y un metodo para preparar dicho organobioartificial | |
IT1269185B (it) | Associazione dotata di effetto sinergico che ha un effetto antagonista dei recettori nk1 e nk2 | |
BR0307413A (pt) | Terapêutica com bloqueadores de aldosterona para prevenção ou tratamento de patologias relacionadas com inflamação | |
ZA200609220B (en) | Method of treating dry eye disorders and uveitis | |
GT200200164A (es) | Metodo para el tratamiento del insomnio primario | |
MXPA00010254A (es) | Tratamiento de disfuncion sexual en ciertos grupos de pacientes. | |
DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
WO2003103699A8 (en) | USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS | |
BRPI0507302A (pt) | método e composições para o tratamento da lipodistrofia | |
MY147886A (en) | Method for the treatment of bone disorders | |
JO3448B1 (ar) | استخدام أزيثروميسين لتصنيع دواء لمعالجة إلتهابات العين | |
BR0016646A (pt) | Método para tratar um paciente que sofre de dor, e, composição farmacêutica | |
ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
BR0012121A (pt) | Derivado de aminotetralina para terapia de doenças cardiovasculares |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |